Company Filing History:
Years Active: 2025
Title: Yubin Lv: Innovator in Indole Derivatives
Introduction
Yubin Lv is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on indole derivatives. His research focuses on developing compounds that can effectively treat various autoimmune and inflammatory diseases.
Latest Patents
Yubin Lv holds a patent for an indole derivative and its application in drug development. The invention relates to a specific indole derivative represented by general formula (I-1). This compound is designed to prevent and treat conditions associated with S1P receptor-related disorders. The modified indole derivative exhibits excellent biological activity, making it an ideal S1P receptor regulator with high efficiency. The compounds derived from this formula can be utilized to address a range of health issues, including Crohn's disease, ulcerative colitis, psoriasis, rheumatoid arthritis, multiple sclerosis, and various other autoimmune and inflammatory diseases.
Career Highlights
Yubin Lv is currently employed at Shanghai Medicilon Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating complex medical conditions.
Collaborations
Yubin collaborates with notable colleagues, including Feng Ren and Hailong Wang, who contribute to his research initiatives and help drive innovation within the company.
Conclusion
Yubin Lv's contributions to the field of pharmaceuticals through his indole derivative patent highlight his role as an influential inventor. His work has the potential to significantly improve treatment options for various autoimmune and inflammatory diseases.